发明名称 Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
摘要 A synthesis approach providing an early ring attachment via a bromination to compound 1-1 yielding compound II-II, whereby a final product such as AA can be synthesized. In particular, the 2,4-difluorophenyl-containing sidechain is attached before creation of the additional ring Q.;
申请公布号 US9242986(B2) 申请公布日期 2016.01.26
申请号 US201414272823 申请日期 2014.05.08
申请人 SHIONOGI & CO., LTD.;ViiV Healthcare Company 发明人 Kawasuji Takashi;Nagamatsu Daiki
分类号 C07D471/22;A61K31/351;A61K31/4412;C07D487/22;C07D498/14 主分类号 C07D471/22
代理机构 Wenderoth, Lind & Ponack, L.L.P. 代理人 Wenderoth, Lind & Ponack, L.L.P.
主权项 1. A crystal form of a sodium salt of a compound of formula AA having characteristic diffraction peaks at 6.4°±0.2°, 9.2°±0.2°, 13.8°±0.2°, 19.2°±0.2° and 21.8°±0.2° degrees two-theta in an X-ray powder diffraction pattern.
地址 Osaka JP